Citations

Clear

410 citation(s) found for "Shu, Yu".

Evaluation of feasibility of 1.5 Tesla prostate MRI using body coil RF transmit in a patient with an implanted vagus nerve stimulator
Favazza, Christopher , Edmonson, Heidi A. , Shu, Yunhong , Felmlee, Joel P. , Watson, Robert E. , Gorny, Krzysztof R. , Favazza, Christopher P, Ma, Chi , Ma, Chi

Mayo Clinic

Medical Physics | September 7, 2017 | Volume: 44 | Issue: 11 | Pages: 5749-5754

10.1002/mp.12567 | PMID 28880381 Get It

PurposeTo assess risks of RF‐heating of a vagus nerve stimulator (VNS) during 1.5 T prostate MRI using body coil transmit and to compare these risks with those associated with MRI head exams using a transmit/receive head coil.MethodsSpatial distributions of radio‐frequency (RF) B1 fields generated by transmit/receive (T/R) body and head coils were empirically assessed along the long axis of a 1.5 T MRI scanner bore. Measurements were obtained along the center axis of the scanner and laterally offset by 15 cm (body coil) and 7 cm (head coil). RF‐field measurements were supplemented with direct measurements of RF‐heating of 15 cm long copper wires affixed to and submerged in the “neck” region of the gelled saline‐filled (sodium chloride and polyacrylic acid) “head‐and‐torso” phantom. Temperature elevations at the lead tips were measured using fiber‐optic thermometers with the phantom positioned at systematically increased distances from the scanner isocenter.ResultsB1 field measurements demonstrated greater than 10 dB reduction in RF power at distances beyond 28 cm and 24 cm from isocenter for body and head coil, respectively. Moreover, RF power from body coil transmit at distances greater than 32 cm from isocenter was found to be lower than from the RF power from head coil transmit measured at locations adjacent to the coil array at its opening. Correspondingly, maximum temperature elevations at the tips of the copper wires decreased with increasing distance from isocenter — from 7.4°C at 0 cm to no appreciable heating at locations beyond 40 cm.ConclusionsFor the particular scanner model evaluated in this study, positioning an implanted VNS farther than 32 cm from isocenter (configuration achievable for prostate exams) can reduce risks of RF‐heating resulting from the body coil transmit to those associated with using a T/R head coil.
Magnetization‐prepared shells trajectory with automated gradient waveform design
Shu, Yunhong , Tao, Shengzhen , Trzasko, Joshua D. , Weavers, Paul T., Bernstein, Matt A. , Bernstein, Matt A , Huston, John

Mayo Clinic

Magnetic Resonance in Medicine | August 22, 2017 | Volume: 79 | Issue: 4 | Pages: 2024-2035

10.1002/mrm.26863 | PMID 28833440 Get It

PurposeTo develop a fully automated trajectory and gradient waveform design for the non‐Cartesian shells acquisition, and to develop a magnetization‐prepared (MP) shells acquisition to achieve an efficient three‐dimensional acquisition with improved gray‐to‐white brain matter contrast.MethodsAfter reviewing the shells k‐space trajectory, a novel, fully automated trajectory design is developed that allows for gradient waveforms to be automatically generated for specified acquisition parameters. Designs for two types of shells are introduced, including fully sampled and undersampled/accelerated shells. Using those designs, an MP‐Shells acquisition is developed by adjusting the acquisition order of shells interleaves to synchronize the center of k‐space sampling with the peak of desired gray‐to‐white matter contrast. The feasibility of the proposed design and MP‐Shells is demonstrated using simulation, phantom, and volunteer subject experiments, and the performance of MP‐Shells is compared with a clinical Cartesian magnetization‐prepared rapid gradient echo acquisition.ResultsInitial experiments show that MP‐Shells produces excellent image quality with higher data acquisition efficiency and improved gray‐to‐white matter contrast‐to‐noise ratio (by 36%) compared with the conventional Cartesian magnetization‐prepared rapid gradient echo acquisition.ConclusionWe demonstrated the feasibility of a three‐dimensional MP‐Shells acquisition and an automated trajectory design to achieve an efficient acquisition with improved gray‐to‐white matter contrast. Magn Reson Med 79:2024–2035, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate
Qiu, Shu-Dong, Bilhartz, David L., Prescott, James L. , Farrow, George M., He, Wei-Wu, Tindall, Donald J., Young, Charles Y.F.

Mayo Clinic

Journal of Urology | June 29, 2017 | Volume: 144 | Issue: 6 | Pages: 1550-1556

10.1016/s0022-5347(17)39797-5 | PMID 1700164 Get It

The effect of concomitant fields in fast spin echo acquisition on asymmetric MRI gradient systems
Tao, Shengzhen , Weavers, Paul T., Trzasko, Joshua D. , Shu, Yunhong , Gray, Erin M. , Foo, Thomas , Bernstein, Matt A. , Bernstein, Matt A , Huston, John , Foo, Thomas K F

Mayo Clinic

Magnetic Resonance in Medicine | June 23, 2017 | Volume: 79 | Issue: 3 | Pages: 1354-1364

10.1002/mrm.26789 | PMID 28643408 Get It

PurposeTo investigate the effect of the asymmetric gradient concomitant fields (CF) with zeroth and first‐order spatial dependence on fast/turbo spin‐echo acquisitions, and to demonstrate the effectiveness of their real‐time compensation.MethodsAfter briefly reviewing the CF produced by asymmetric gradients, the effects of the additional zeroth and first‐order CFs on these systems are investigated using extended‐phase graph simulations. Phantom and in vivo experiments are performed to corroborate the simulation. Experiments are performed before and after the real‐time compensations using frequency tracking and gradient pre‐emphasis to demonstrate their effectiveness in correcting the additional CFs. The interaction between the CFs and prescan‐based correction to compensate for eddy currents is also investigated.ResultsIt is demonstrated that, unlike the second‐order CFs on conventional gradients, the additional zeroth/first‐order CFs on asymmetric gradients cause substantial signal loss and dark banding in fast spin‐echo acquisitions within a typical brain‐scan field of view. They can confound the prescan correction for eddy currents and degrade image quality. Performing real‐time compensation successfully eliminates the artifacts.ConclusionsWe demonstrate that the zeroth/first‐order CFs specific to asymmetric gradients can cause substantial artifacts, including signal loss and dark bands for brain imaging. These effects can be corrected using real‐time compensation. Magn Reson Med 79:1354–1364, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
B0 concomitant field compensation for MRI systems employing asymmetric transverse gradient coils
Weavers, Paul T., Tao, Shengzhen , Trzasko, Joshua D. , Frigo, Louis M., Shu, Yunhong , Frick, Matthew A., Foo, Thomas , Bernstein, Matt A. , Bernstein, Matt A , Lee, Seung‐Kyun , Foo, Thomas K F

Mayo Clinic

Magnetic Resonance in Medicine | June 22, 2017 | Volume: 79 | Issue: 3 | Pages: 1538-1544

10.1002/mrm.26790 | PMID 28639370 Get It

PurposeImaging gradients result in the generation of concomitant fields, or Maxwell fields, which are of increasing importance at higher gradient amplitudes. These time‐varying fields cause additional phase accumulation, which must be compensated for to avoid image artifacts. In the case of gradient systems employing symmetric design, the concomitant fields are well described with second‐order spatial variation. Gradient systems employing asymmetric design additionally generate concomitant fields with global (zeroth‐order or B0) and linear (first‐order) spatial dependence.MethodsThis work demonstrates a general solution to eliminate the zeroth‐order concomitant field by applying the correct B0 frequency shift in real time to counteract the concomitant fields. Results are demonstrated for phase contrast, spiral, echo‐planar imaging (EPI), and fast spin‐echo imaging.ResultsA global phase offset is reduced in the phase‐contrast exam, and blurring is virtually eliminated in spiral images. The bulk image shift in the phase‐encode direction is compensated for in EPI, whereas signal loss, ghosting, and blurring are corrected in the fast‐spin echo images.ConclusionA user‐transparent method to compensate the zeroth‐order concomitant field term by center frequency shifting is proposed and implemented. This solution allows all the existing pulse sequences—both product and research—to be retained without any modifications. Magn Reson Med 79:1538–1544, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Linking smokers to a quitline: randomized controlled effectiveness trial of a support person intervention that targets non-smokers
Tinkelman, David, Lukowski, Amy V., Decker, Paul A. , D’Silva, Joanne , Lichtenstein, Edward, Patten, Christi A. , Brockman, Tabetha A. , Boyle, Raymond G. , Decker, Paul A. , Zhu, Shu-Hong

Mayo Clinic

Health Education Research | June 13, 2017 | Volume: 32 | Issue: 4 | Pages: 318-331

10.1093/her/cyx050 | PMID 28854569 Get It

CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST‐LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE.
Fornecker, Luc-Mathieu, Sebban, Catherine, Marcus, R. E., Höchster, Howard S. , Rummel, Mathias , Hagenbeeck, A., Herold, Michael , Nielsen, Tina, Foon, K., Flowers, Christopher R. , Shi, Q., Ou, Fang‐Shu , Dixon, Jesse G. , Casulo, Carla , Hoster, Eva , Klapper, Wolfram , Morschhauser, Franck , Kimby, Eva , Peterson, B.A., Gyan, Emmanuel , Ladetto, Marco , Zucca, Emanuele , Vitolo, Umberto , Shi, Q., Salles, Gilles

Mayo Clinic

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 225-226

10.1002/hon.2438_89 Get It

Cell‐free DNA copy number variations in plasma from colorectal cancer patients
Li, Jian , Dittmar, Rachel L. , Xia, Shu , Zhang, Huijuan , Du, Meijun , Huang, Chiang‐Ching , Druliner, Brooke R., Boardman, Lisa, Wang, Liang , Druliner, Brooke R. , Boardman, Lisa, Wang, Liang

Mayo Clinic

Molecular Oncology | May 15, 2017 | Volume: 11 | Issue: 8 | Pages: 1099-1111

10.1002/1878-0261.12077 | PMID 28504856 Get It

To evaluate the clinical utility of cell‐free DNA (cfDNA), we performed whole‐genome sequencing to systematically examine plasma cfDNA copy number variations (CNVs) in a cohort of patients with colorectal cancer (CRC, n = 80), polyps (n = 20), and healthy controls (n = 35). We initially compared cfDNA yield in 20 paired serum–plasma samples and observed significantly higher cfDNA concentration in serum (median = 81.20 ng, range 7.18–500 ng·mL−1) than in plasma (median = 5.09 ng, range 3.76–62.8 ng·mL−1) (P < 0.0001). However, tumor‐derived cfDNA content was significantly lower in serum than in matched plasma samples tested. With ~10 million reads per sample, the sequencing‐based copy number analysis showed common CNVs in multiple chromosomal regions, including amplifications on 1q, 8q, and 5q and deletions on 1p, 4q, 8p, 17p, 18q, and 22q. Copy number changes were also evident in genes critical to the cell cycle, DNA repair, and WNT signaling pathways. To evaluate whether cumulative copy number changes were associated with tumor stages, we calculated plasma genomic abnormality in colon cancer (PGA‐C) score by summing the most significant CNVs. The PGA‐C score showed predictive performance with an area under the curve from 0.54 to 0.84 for CRC stages I‐IV. Locus‐specific copy number analysis identified nine genomic regions where CNVs were significantly associated with survival in stage III‐IV CRC patients. A multivariate model using six of nine genomic regions demonstrated a significant association of high‐risk score with shorter survival (HR = 5.33, 95% CI = 6.76–94.44, P < 0.0001). Our study demonstrates the importance of using plasma (rather than serum) to test tumor‐related genomic variations. Plasma cfDNA‐based tests can capture tumor‐specific genetic changes and may provide a measurable classifier for assessing clinical outcomes in advanced CRC patients.
Assembly of filamentous tau aggregates in human neuronal cells
Ko, Li‐wen, Rush, Toni, Kersh, Jay S., Easson, Colin, DeTure, Michael , Lin, Wen-Lang, Connor, Yamicia , Yen, Shu-Hui, Sahara, Naruhiko

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 6 | Issue: 6 | Pages: 605-622

10.3233/jad-2004-6605 | PMID 15665401 Get It

Outcomes in the second line treatment of metastatic colorectal cancer (mCRC): Findings from 6,462 patients (pts) in the ARCAD database.
Gramont, Aimery de , Pederson, Levi , Sobrero, Alberto F. , Pitot, Henry C., Rothenberg, Mace L., Giantonio, Bruce J. , Grothey, Axel, Leal, Alexis D. , Ou, Fang‐Shu , Peeters, Marc , Arnold, Dirk , Cutsem, Eric Van , Sargent, Daniel J.

Mayo Clinic

Journal of Clinical Oncology | March 21, 2017 | Volume: 35 | Issue: 4_suppl | Pages: 757-757

10.1200/jco.2017.35.4_suppl.757 Get It

757 Background: Progression free survival (PFS) and overall survival (OS) appear to differ across trials, even when pts receive the same regimen (REG). This analysis aimed to benchmark the clinical outcomes in the 2nd line treatment of metastatic colorectal cancer (mCRC). Methods: Individual patient (pt) data was available on 6,462 pts with mCRC enrolled in 7 2ndline clinical trials (8 REGs) in the ARCAD database. Regimens used in at least two trials included FOLFIRI +/- an EGFR inhibitor (EGFRi), FOLFOX +/- a VEGF inhibitor (VEGFi), and irinotecan (IRI). Descriptive statistics were used to describe pt demographics. Multivariable Cox models were used to assess differences (DIFFs) in PFS and OS, while p-value <0.05 were considered statistically significant (SS). Results: 500-1400 pts received each REG (see Table). Median OS and PFS differed by 0.2 to 4.6 months (mo) and 0.8 to 2.5 mo across trials within the same REG. These DIFFs were SS except for PFS in REGs containing FOLFIRI +/- EGFRi. After multivariable adjustment, all DIFFs in OS were attenuated and non-significant. DIFFs in PFS attenuated for most REGs but remained SS for FOLFOX and IRI. Conclusions: After multivariable adjustment, there were no SS DIFFs in outcomes across trials within the same REG, with the exception of PFS in FOLFOX and IRI. The initial observed DIFFs in outcomes could be due to confounding factors and the remaining SS DIFFs in PFS in FOLFOX and IRI may be due to variation in definition of progression across trials. Therefore, caution is warranted when using historical data to design future trials.[Table: see text]